Back to 
TCW Group Inc.
TCW Group Inc.
AMRX
Showing 0 of 2 quarters
Position history for TCW Group Inc.'s holdings in Amneal Pharmaceuticals, Inc.
No. TCW Group exited its AMRX (Amneal Pharmaceuticals) position in Q2 2019. Its Q1 2019 13F listed 2,302,363 shares worth $32.6M. TCW Group already held AMRX in its Q1 2019 13F, the earliest on record, and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.